More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested.
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
Adult diabetes cases worldwide have more than quadrupled, according to a new analysis from The Lancet journal.
KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.
KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediatorâ„¢ VAR 200 in patients with diabetic kidney disease expected to ...
Hosted on MSN19h
9 crucial facts about diabetes, from worrying trends and how to avoid it, to ‘diabesity’On World Diabetes Day, we talk to experts about the causes, symptoms and treatment of type 1 and 2 diabetes ... That can ...
Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.
People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback